↓ Skip to main content

Cochrane Database of Systematic Reviews

Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia

Overview of attention for article published in Cochrane database of systematic reviews, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

blogs
1 blog
twitter
15 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
161 Mendeley
Title
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
Published in
Cochrane database of systematic reviews, November 2018
DOI 10.1002/14651858.cd010060.pub2
Pubmed ID
Authors

Smita Pattanaik, Ravimohan S Mavuduru, Arabind Panda, Joseph L Mathew, Mayank M Agarwal, Eu Chang Hwang, Jennifer A Lyon, Shrawan K Singh, Arup K Mandal

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 161 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 13%
Student > Ph. D. Student 11 7%
Student > Bachelor 11 7%
Other 10 6%
Researcher 10 6%
Other 22 14%
Unknown 76 47%
Readers by discipline Count As %
Medicine and Dentistry 32 20%
Nursing and Health Professions 14 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Social Sciences 6 4%
Economics, Econometrics and Finance 3 2%
Other 13 8%
Unknown 85 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 August 2022.
All research outputs
#1,882,776
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#3,990
of 13,140 outputs
Outputs of similar age
#35,984
of 338,328 outputs
Outputs of similar age from Cochrane database of systematic reviews
#100
of 242 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 338,328 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 242 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.